AQR Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
AQR Capital Management's ORIC Position: Q3 2026 in Review
AQR Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 64% in Q3 2026, buying an estimated $2.86M and bringing the position to 588,639 shares worth $7.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1732.
AQR Capital Management first reported a position in ORIC in Q2 2022 and has held it in 12 quarters since. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- AQR Capital Management held 588,639 shares of Oric Pharmaceuticals worth $7.93M as of Q3 2026.
- AQR Capital Management bought 229,888 Oric Pharmaceuticals shares in Q3 2026, an estimated $2.86M.
- Oric Pharmaceuticals made up ﹤0.01% of AQR Capital Management's portfolio in Q3 2026, its #1732 holding.
- AQR Capital Management first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 12 quarters since.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.